Bellwether Advisors, LLC Amgen Inc Transaction History

Bellwether Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $4,290 - $5,228	19 Added 19.79%	115 $27,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $2,519 - $3,201	11 Added 12.94%	96 $25,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 1.19%	85 $19,000
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $2,076 - $2,310	9 Added 12.0%	84 $20,000
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $4,574 - $5,234	-23 Reduced 23.47%	75 $16,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $4,033 - $4,725	19 Added 24.05%	98 $20,000
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $17,094 - $20,355	79 New	79 $18,000

3,124

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bellwether Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellwether Advisors, LLC with notifications on news.